A systematic review evaluates treatment options for refractory nontuberculous mycobacterial pulmonary disease, suggesting individualized approaches.
This systematic review underscores the complexity of managing refractory NTM-PD, highlighting the role of treatment intensification, symptom control, supportive measures, and knowledge gaps. While no standardised approach exists, individualised strategies incorporating clinical, microbiological, and radiological factors remain essential for optimising patient outcomes.
No takes yet. Share an insight, caveat, or question.
Moreira-Sousa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: